414 related articles for article (PubMed ID: 33785626)
41. Multiple functions are mediated by the miRNAs of Epstein-Barr virus.
Kuzembayeva M; Hayes M; Sugden B
Curr Opin Virol; 2014 Aug; 7():61-5. PubMed ID: 24814666
[TBL] [Abstract][Full Text] [Related]
42. Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.
Navari M; Etebari M; Ibrahimi M; Leoncini L; Piccaluga PP
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649101
[TBL] [Abstract][Full Text] [Related]
43. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
[TBL] [Abstract][Full Text] [Related]
44. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
Hahn AM; Huye LE; Ning S; Webster-Cyriaque J; Pagano JS
J Virol; 2005 Aug; 79(15):10040-52. PubMed ID: 16014964
[TBL] [Abstract][Full Text] [Related]
45. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.
Marquitz AR; Mathur A; Chugh PE; Dittmer DP; Raab-Traub N
J Virol; 2014 Jan; 88(2):1389-93. PubMed ID: 24227849
[TBL] [Abstract][Full Text] [Related]
46. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion.
Pegtel DM; van de Garde MD; Middeldorp JM
Biochim Biophys Acta; 2011; 1809(11-12):715-21. PubMed ID: 21855666
[TBL] [Abstract][Full Text] [Related]
47. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
48. Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis.
Giudice A; D'Arena G; Crispo A; Tecce MF; Nocerino F; Grimaldi M; Rotondo E; D'Ursi AM; Scrima M; Galdiero M; Ciliberto G; Capunzo M; Franci G; Barbieri A; Bimonte S; Montella M
Oxid Med Cell Longev; 2016; 2016():6021934. PubMed ID: 26977250
[TBL] [Abstract][Full Text] [Related]
49. Analysis of Viral and Cellular MicroRNAs in EBV-Infected Cells.
Skalsky RL
Methods Mol Biol; 2017; 1532():133-146. PubMed ID: 27873272
[TBL] [Abstract][Full Text] [Related]
50. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.
Forte E; Luftig MA
Microbes Infect; 2011 Dec; 13(14-15):1156-67. PubMed ID: 21835261
[TBL] [Abstract][Full Text] [Related]
51. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
[TBL] [Abstract][Full Text] [Related]
52. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
54. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo.
Feldman ER; Kara M; Coleman CB; Grau KR; Oko LM; Krueger BJ; Renne R; van Dyk LF; Tibbetts SA
mBio; 2014 May; 5(3):e00981-14. PubMed ID: 24865551
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr Virus Envelope Glycoprotein gp110 Inhibits IKKi-Mediated Activation of NF-κB and Promotes the Degradation of β-Catenin.
Guo Y; Pan L; Wang L; Wang S; Fu J; Luo W; Wang K; Li X; Huang C; Liu Y; Kang H; Zeng Q; Fu X; Huang Z; Li W; He Y; Li L; Peng T; Yang H; Li M; Xiao B; Cai M
Microbiol Spectr; 2023 Jun; 11(3):e0032623. PubMed ID: 37022262
[TBL] [Abstract][Full Text] [Related]
56. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
Fu W; Verma D; Burton A; Swaminathan S
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
[TBL] [Abstract][Full Text] [Related]
57. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
58. Reevaluating the Impact of Epstein-Barr Virus Noncoding RNAs on the Interferon Response.
Murphy EA
mBio; 2021 Aug; 12(4):e0070021. PubMed ID: 34425704
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.
Mrozek-Gorska P; Buschle A; Pich D; Schwarzmayr T; Fechtner R; Scialdone A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16046-16055. PubMed ID: 31341086
[TBL] [Abstract][Full Text] [Related]
60. An update: Epstein-Barr virus and immune evasion via microRNA regulation.
Zuo L; Yue W; Du S; Xin S; Zhang J; Liu L; Li G; Lu J
Virol Sin; 2017 Jun; 32(3):175-187. PubMed ID: 28669004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
